10x Genomics Price to Sales Ratio 2018-2024 | TXG

Historical PS ratio values for 10x Genomics (TXG) over the last 10 years. The current P/S ratio for 10x Genomics as of May 03, 2024 is . For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
10x Genomics P/S Ratio Historical Data
Date Stock Price TTM Sales per Share Price to Sales Ratio
2024-05-03 27.48 5.17
2024-03-31 37.53 $5.31 7.06
2023-12-31 55.96 $5.29 10.57
2023-09-30 41.25 $5.10 8.09
2023-06-30 55.84 $4.94 11.30
2023-03-31 55.79 $4.69 11.89
2022-12-31 36.44 $4.54 8.02
2022-09-30 28.48 $4.47 6.37
2022-06-30 45.25 $4.45 10.16
2022-03-31 76.07 $4.50 16.91
2021-12-31 148.96 $4.46 33.41
2021-09-30 145.58 $4.27 34.12
2021-06-30 195.82 $3.85 50.92
2021-03-31 181.00 $3.22 56.13
2020-12-31 141.60 $2.99 47.29
2020-09-30 124.68 $2.67 46.72
2020-06-30 89.31 $4.06 22.01
Sector Industry Market Cap Revenue
Medical Medical Information Systems $3.275B $0.619B
10x Genomics Inc. is a life science technology company. It develops and sells instruments, consumables and software for analyzing biological systems. 10x Genomics Inc. is based in Pleasanton, California.
Stock Name Country Market Cap PE Ratio
GE HealthCare Technologies (GEHC) United States $36.275B 19.92
Inspire Medical Systems (INSP) United States $7.566B 0.00
Axonics (AXNX) United States $3.432B 0.00
IRhythm Technologies (IRTC) United States $3.196B 0.00
Azenta (AZTA) United States $2.979B 242.82
Olink Holding AB (publ) (OLK) Sweden $2.861B 0.00
Enovis (ENOV) United States $2.812B 20.84
Hims & Hers Health (HIMS) United States $2.412B 0.00
Privia Health (PRVA) United States $2.224B 98.63
Schrodinger (SDGR) United States $1.712B 0.00
Omnicell (OMCL) United States $1.384B 47.83
Phreesia (PHR) United States $1.259B 0.00
Definitive Healthcare (DH) United States $0.828B 0.00
Standard BioTools (LAB) United States $0.728B 0.00
Fulgent Genetics (FLGT) United States $0.643B 0.00
Talkspace (TALK) United States $0.538B 0.00
Health Catalyst (HCAT) United States $0.383B 0.00
Pulmonx (LUNG) United States $0.378B 0.00
Clover Health Investments (CLOV) United States $0.344B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.326B 0.00
P3 Health Partners (PIII) United States $0.202B 0.00
Butterfly Network (BFLY) United States $0.196B 0.00
American Well (AMWL) United States $0.165B 0.00
Outset Medical (OM) United States $0.162B 0.00
Augmedix (AUGX) United States $0.133B 0.00
MSP Recovery (LIFW) United States $0.125B 0.00
TruBridge (TBRG) United States $0.125B 5.33
Mobile-health Network Solutions (MNDR) Singapore $0.108B 0.00
111 (YI) China $0.096B 0.00
Future Health ESG (FHLT) United States $0.071B 0.00
SHL Telemedicine (SHLT) Israel $0.068B 0.00
HeartBeam (BEAT) United States $0.058B 0.00
Zepp Health (ZEPP) China $0.053B 0.00
Movano (MOVE) United States $0.046B 0.00
EUDA Health Holdings (EUDA) Singapore $0.044B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.034B 0.00
Akili (AKLI) United States $0.032B 0.00
Bullfrog AI Holdings (BFRG) United States $0.024B 0.00
Cue Health (HLTH) United States $0.022B 0.00
Streamline Health Solutions (STRM) United States $0.019B 0.00
CareCloud (CCLD) United States $0.018B 0.00
ETAO (ETAO) United States $0.016B 0.00
Strata Skin Sciences (SSKN) United States $0.015B 0.00
Biotricity (BTCY) United States $0.012B 0.00
Transgenomic (PRPO) United States $0.009B 0.00
Syra Health (SYRA) United States $0.008B 0.00
Predictive Oncology (POAI) United States $0.007B 0.00
Healthcare Triangle (HCTI) United States $0.006B 0.00
HeartSciences (HSCS) United States $0.006B 0.00
Zhongchao (ZCMD) China $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Centogene (CNTG) Germany $0.000B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00